Search

Your search keyword '"SURGICAL technology"' showing total 5,274 results
Start Over Descriptor "SURGICAL technology" Topic surgical instruments
5,274 results on '"SURGICAL technology"'

1. Intraoperative navigation in craniofacial surgery.

Author

Dong Hee Kang

Subjects
*LEARNING curve, *EYE-socket fractures, *SURGICAL technology, *FACIAL bones, *SURGICAL instruments
Abstract

Craniofacial surgery requires comprehensive anatomical knowledge of the head and neck to ensure patient safety and surgical precision. Over recent decades, there have been significant advancements in imaging techniques and the development of real-time surgical navigation systems. Intraoperative navigation technology aligns surgical instruments with imaging-derived information on patient anatomy, enabling surgeons to closely follow preoperative plans. This system functions as a radiologic map, improving the accuracy of instrument placement and minimizing surgical complications. The introduction of first-generation navigation systems in the early 1990s revolutionized surgical procedures by enabling real-time tracking of instruments using preoperative imaging. Initially utilized in neurosurgery, intraoperative navigation has since become standard practice in otolaryngology, cranio-maxillofacial surgery, and orthopedics. Since the 2000s, second-generation navigation systems have been developed to meet the growing demand for precision across various surgical specialties. The adoption of these systems in craniofacial surgery has been slower, but their use is increasing, particularly in procedures such as foreign body removal, facial bone fracture reconstruction, tumor resection, and craniofacial reconstruction and implantation. In Korea, insurance coverage for navigation in craniofacial surgery began in 2021, and new medical technologies for orbital wall fracture treatment were approved in August 2022. These technologies have only recently become clinically available, but are expected to play an increasingly important role in craniofacial surgery. Intraoperative navigation enhances operative insight, improves target localization, and increases surgical safety. Although these systems have a steep learning curve and initially prolong surgery, efficiency improves with experience. Calibration issues, registration errors, and soft tissue deformation can introduce inaccuracies. Nonetheless, navigation technology is evolving, and the integration of intraoperative computed tomography data holds promise for further enhancements of surgical accuracy. This paper discusses the various types and applications of navigation employed in craniofacial surgery, highlighting their benefits and limitations. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

2. Deep learning for surgical instrument recognition and segmentation in robotic-assisted surgeries: a systematic review.

Author

Ahmed, Fatimaelzahraa Ali, Yousef, Mahmoud, Ahmed, Mariam Ali, Ali, Hasan Omar, Mahboob, Anns, Ali, Hazrat, Shah, Zubair, Aboumarzouk, Omar, Al Ansari, Abdulla, and Balakrishnan, Shidin

Subjects
SURGICAL equipment, MINIMALLY invasive procedures, TECHNOLOGICAL innovations, SURGICAL technology, SURGICAL instruments
Abstract

Applying deep learning (DL) for annotating surgical instruments in robot-assisted minimally invasive surgeries (MIS) represents a significant advancement in surgical technology. This systematic review examines 48 studies that utilize advanced DL methods and architectures. These sophisticated DL models have shown notable improvements in the precision and efficiency of detecting and segmenting surgical tools. The enhanced capabilities of these models support various clinical applications, including real-time intraoperative guidance, comprehensive postoperative evaluations, and objective assessments of surgical skills. By accurately identifying and segmenting surgical instruments in video data, DL models provide detailed feedback to surgeons, thereby improving surgical outcomes and reducing complication risks. Furthermore, the application of DL in surgical education is transformative. The review underscores the significant impact of DL on improving the accuracy of skill assessments and the overall quality of surgical training programs. However, implementing DL in surgical tool detection and segmentation faces challenges, such as the need for large, accurately annotated datasets to train these models effectively. The manual annotation process is labor-intensive and time-consuming, posing a significant bottleneck. Future research should focus on automating the detection and segmentation process and enhancing the robustness of DL models against environmental variations. Expanding the application of DL models across various surgical specialties will be essential to fully realize this technology's potential. Integrating DL with other emerging technologies, such as augmented reality (AR), also offers promising opportunities to further enhance the precision and efficacy of surgical procedures. [ABSTRACT FROM AUTHOR]

Published
2025
Full Text
View/download PDF

3. Can gamified surgical sets improve surgical instrument recognition and student performance retention in the operating room? A multi-institutional experimental crossover study.

Author

Masoumian Hosseini, Mohsen, Sadat Manzari, Zahra, Gazerani, Azam, Masoumian Hosseini, Seyedeh Toktam, Gazerani, Akram, and Rohaninasab, Mehrdad

Subjects
SURGICAL instruments, OPERATING rooms, SCHOOL dropout prevention, SURGICAL education, ONE-way analysis of variance, SURGICAL technology
Abstract

Introduction: Surgery requires a high degree of precision, speed, and concentration. Owing to the complexity of the modern world, traditional methods cannot meet these requirements. Therefore, in this study, we investigated students' diagnostic skills in the Operating Room in the context of surgical instruments by using gamification of surgical instruments and a crossover design. Method: The study design was a multi-institutional quasi-experimental crossover and involved a three-arm intervention (with gender-specific block randomisation: Group A, B, and C) with a pre-test and three post-tests. A total of 90 students fell into three groups of 30 participants each. The surgical sets were learned for one semester through game-based instruction and traditional teaching, and then three OSCE tests were administered with time and location differences. Using one-way ANOVA, OSCE results were compared in the game, traditional, and control groups. The effectiveness of the intervention was tested in each group by repeated measures. Result: The pretest scores of all three groups did not differ significantly. In the OSCE tests, both groups, A and B, performed similarly. However, these tests showed a significant difference in grouping between training through games and training in the traditional way. There was no significant difference between OSCE tests 2 and 3 in the game-based training group, indicating that what was learned was retained, while in the traditional method training group, OSCE 3 test scores declined significantly. Furthermore, repeated measures showed the effectiveness of game-based training. Conclusion: In this study, gamification has turned out to be very effective in helping learners learn practical skills and leading to more sustainable learning. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

4. Information loss challenges in surgical navigation systems: From information fusion to AI-based approaches.

Author

Xu, Lisheng, Zhang, Haoran, Wang, Jiaole, Li, Ang, Song, Shuang, Ren, Hongliang, Qi, Lin, Gu, Jason J., and Meng, Max Q.-H.

Subjects
*AUTOMOTIVE navigation systems, *ARTIFICIAL intelligence, *MINIMALLY invasive procedures, *SURGICAL technology, *SURGICAL instruments, *INFORMATION storage & retrieval systems
Abstract

• Focus on the information loss problem in tracking technologies for surgical navigation systems. • Survey the existing solutions to information loss in tracking surgical instruments. • Information fusion technology to improve accuracy, precision, and stability. • Future research trends on information fusion during surgical navigation. Surgical navigation technology provides minimally invasive surgery (MIS) with the relative pose relationships amongst medical images, surgical instruments, and lesions. On the other hand, traditional operation procedures depend heavily on direct surgical field exposure. Consequently, introducing surgical navigation can enable surgeons to operate more accurately and efficiently. A tracking system is a core enabling technology of a surgical navigation system. In this paper, after reviewing the tracking technologies, we compare and analyze their pros and cons, and find that information loss is a common challenge. The information loss problem is an inherent drawback in mono-modality surgical navigation systems. It is characterized by physical constraints, attenuation, breakdown of signal, and accuracy instability of the tracking algorithms. This review focuses on the information loss problem in tracking technologies for surgical navigation systems. Furthermore, we survey the existing solutions that aim at tackling the information loss problem, especially in the information fusion of surgical tracking technologies, and we also summarize their key improvements and limitations. Particular attention has been given to the modalities, approaches, objectives, and surgical application scenarios, which can improve the accuracy, precision, and stability of surgical navigation systems. Finally, future research trends directed at improving the information loss problem are discussed, i.e., tight integration of sensing technology, augmented reality for visualization in surgical tracking, stable high-speed 5G networks for telesurgery, strong intelligence and affordable service. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

5. Integrity of Human Mandibular Angle After Block Graft Harvest from Mandibular Body.

Author

Sittitavornwong, Somsak, Ashley, David, Denson, Douglas, and Cruz Walma, David A.

Subjects
MANDIBLE surgery, COMPACT bone, DEAD, ORGAN donation, MANDIBLE, DENTAL occlusion, OSTEOTOMY, HEALTH outcome assessment, POLYMETHYLMETHACRYLATE, STATURE, SURGICAL instruments, SURGICAL technology, TRANSPLANTATION of organs, tissues, etc., DATA analysis, STATISTICAL significance, DESCRIPTIVE statistics
Abstract

Purpose: To examine human mandibular angle integrity alterations accompanying a mandibular body block graft harvest surgical procedure. Materials and Methods: Hemimandibles from 24 human cadavers were resected and sorted into one of three groups by residual dental status. The height of each hemimandible body was obtained and recorded. Acrylic bone cement was utilized to mount the hemimandibles at the mandibular condyle. Using standard surgical instruments and techniques, cortical bone of the mandibular body buccal plate was resected from the right hemimandibles. Left hemimandibles were used as a control. Each hemimandible was secured in an Instron 5565 mechanical unit. With forces placed on and perpendicular to the occlusal plane, each hemimandible underwent sequential loading until osseous fracture occurred. Descriptive statistics between grouped data were compared and discussed in terms of mean, minimum, and maximum. The statistical relationship between the maximal load, sex, and mandibular body height were identified. Results: Donor and control hemimandible maximal load mean values were 423.63 N and 957.90 N, respectively. A statistically significant difference was present between maximal loads of donor and control hemimandibles (P < .0001). Correlations of statistical significance were present between mandibular bone height and maximal load in the control hemimandibles (P = .009). Correlations of statistical significance were not found between mandibular bone height, displacement at maximal load, and maximal load in the grafted hemimandibles (P > .05). No statistically significant correlation between dental status and sex was found in the donor and control hemimandibles (P > .05). Conclusion: After being subjected to a typical block graft harvest surgical procedure, the human mandible's integrity is significantly altered. Sex, dental status, and mandibular bone height do not correlate with maximal load, and thus, integrity, of donor and control mandibles. [ABSTRACT FROM AUTHOR]

Published
2019
Full Text
View/download PDF

6. Inexpensive Materials for Microsurgery in Middle- and Low-Income Countries.

Author

Ciudad, Pedro, Escandón, Joseph M., Llanos, Edgar, Ludeña, Juan, Manrique, Oscar J., Castro, Jorge, and Rossi, Rafael

Subjects
*LOW-income countries, *SURGICAL technology, *OPERATIVE surgery, *SURGICAL instruments, *MICROSURGERY, DEVELOPING countries
Abstract

With the continuous incorporation of new technologies and advancements in surgical technique, microsurgical procedures around the world have generated a higher success rate and innovative procedures are now possible. In this setting, limitations regarding accessibility and acquisition of medical resources and equipment for these types of operations may be difficult in developing countries. We believe the dexterities of surgeons go beyond the surgical technique, meaning that we are able to use everyday materials to re-create affordable solutions that can be used during surgery in a safe way. This manuscript presents our experience with different surgical instruments and gadgets, developed out of necessity, to improve microsurgical interventions in developing countries. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

7. Nyxoah Sa Files SEC Form 6-K, Report of Foreign Issuer [Rules 13A-16 And 15D-16]: (Oct. 28, 2024).

Subjects
MEDICAL equipment, SURGICAL instruments, SECURITY holders, SURGICAL technology, PUBLIC companies
Abstract

Nyxoah Sa, a company in the surgical and medical instruments and apparatus industry, filed a Form 6-K with the U.S. Securities and Exchange Commission on October 28, 2024. This form is used by certain foreign private issuers to provide information required to be made public in their home country or distributed to shareholders. The filing can be accessed on the SEC's website for more details. [Extracted from the article]

Published
2024

8. Utah Medical Products Inc. Files SEC Form 8-K, Current Report: (Oct. 29, 2024).

Subjects
MEDICAL equipment, SURGICAL instruments, MEDICAL supplies, SECURITY holders, SURGICAL technology
Abstract

Utah Medical Products Inc. filed a Form 8-K with the U.S. Securities and Exchange Commission on October 29, 2024. The company's SIC code is 3841, and the filing included 15 documents. Form 8-K is used to report material events or corporate changes that are important to investors. This SEC filing provides current information on specific events for publicly-traded companies like Utah Medical Products Inc. [Extracted from the article]

Published
2024

9. Catheter Precision, Inc. Files SEC Form 8-K, Current Report: (Oct. 25, 2024).

Subjects
MEDICAL equipment, SURGICAL instruments, SECURITY holders, SURGICAL technology, PUBLIC companies
Abstract

Catheter Precision, Inc. filed a Form 8-K with the U.S. Securities and Exchange Commission on October 25, 2024. The company's SIC code is 3841, and the filing included 18 documents. Form 8-K is used to report material events or corporate changes that are important to investors. This SEC filing provides current information on specific events for publicly-traded companies like Catheter Precision, Inc. [Extracted from the article]

Published
2024

10. Resmed Inc. Files SEC Form DEFA14A, Additional Definitive Proxy Soliciting Materials And Rule 14(A)(12) Material: (Oct. 25, 2024).

Subjects
MEDICAL equipment, SURGICAL instruments, SURGICAL technology, PUBLIC companies, INDUSTRY classification
Abstract

Resmed Inc. filed a U.S. Securities and Exchange Commission (SEC) Form DEFA14A on October 25, 2024. The company's SIC code is 3841, and the filing included 2 documents. The SEC file number is 0001193125-24-244162, and Resmed Inc. is located at 9001 Spectrum Center Blvd., San Diego, CA 92123. This filing is related to additional proxy soliciting materials-definitive, and more information can be found on the SEC website. [Extracted from the article]

Published
2024

11. Allurion Technologies, Inc. Files SEC Form PRE 14A, Other Preliminary Proxy Statements: (Oct. 28, 2024).

Subjects
SURGICAL instruments, MEDICAL equipment, PROXY statements, SURGICAL technology, PUBLIC companies
Abstract

Allurion Technologies, Inc. filed a Form PRE 14A with the U.S. Securities and Exchange Commission on October 28, 2024. The filing pertains to a preliminary proxy statement and is not related to a contested matter or merger/acquisition. Allurion Technologies, Inc. operates in the surgical and medical instruments and apparatus industry, with its contact information located in Natick, MA. [Extracted from the article]

Published
2024

12. Sanuwave Health, Inc. Files SEC Form 8-K, Current Report: (Oct. 25, 2024).

Subjects
SURGICAL instruments, MEDICAL equipment, SECURITY holders, SURGICAL technology, PUBLIC companies
Abstract

Sanuwave Health, Inc. filed a Form 8-K with the U.S. Securities and Exchange Commission on October 25, 2024. The filing pertains to material events or corporate changes important to investors. Sanuwave Health Inc. is a healthcare technology company specializing in surgical and medical instruments and apparatus. The SEC filing provides current information on specific events relevant to the company. [Extracted from the article]

Published
2024

13. Pro Dex Inc. Files SEC Form 8-K, Current Report: (Oct. 25, 2024).

Subjects
SURGICAL instruments, MEDICAL equipment, SECURITY holders, SURGICAL technology, PUBLIC companies
Abstract

Pro Dex Inc. filed a U.S. Securities and Exchange Commission (SEC) Form 8-K on October 25, 2024. The company's SIC code is 3841, and the filing included 13 documents. Form 8-K is used to report material events or corporate changes that are important to investors. This SEC filing provides current information on specific events for publicly-traded companies like Pro Dex Inc. [Extracted from the article]

Published
2024

14. Bioventus Inc. Files SEC Form S-3, Registration Statement Under Securities Act of 1933: (Oct. 25, 2024).

Subjects
SURGICAL instruments, MEDICAL equipment, SURGICAL technology, PUBLIC companies, INDUSTRY classification
Abstract

Bioventus Inc. filed a Form S-3 with the U.S. Securities and Exchange Commission on October 25, 2024. The company's SIC code is 3841, indicating its involvement in Surgical and Medical Instruments and Apparatus. Form S-3 is a simplified registration form used by companies that have been reporting under the '34 Act for at least twelve months and have met timely filing requirements. This SEC filing is a formal document submitted by publicly-traded companies, and more information can be found on the SEC's website. [Extracted from the article]

Published
2024

15. Procept Biorobotics Corp. Files SEC Form 424B5, Prospectus [Rule 424(B)(5)]: (Oct. 30, 2024).

Subjects
SURGICAL instruments, MEDICAL equipment, SURGICAL technology, PUBLIC companies, INDUSTRY classification
Abstract

Procept Biorobotics Corp. filed a Form 424B5 with the U.S. Securities and Exchange Commission on October 30, 2024. The company's SIC code is 3841, focusing on Surgical and Medical Instruments and Apparatus. This filing is a formal document submitted by publicly-traded companies, and more information can be found on the SEC's website. [Extracted from the article]

Published
2024

16. Odyssey Health, Inc. Files SEC Form NT 10-K, Notification of Inability To Timely File Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, Or 10-KT405: (Oct. 30, 2024).

Subjects
SURGICAL instruments, MEDICAL equipment, SURGICAL technology, PUBLIC companies, INDUSTRY classification
Abstract

Odyssey Health, Inc. filed a Form NT 10-K with the U.S. Securities and Exchange Commission (SEC) on October 29, 2024, indicating a notification of late filing. The company's SIC code is 3841, relating to Surgical and Medical Instruments and Apparatus. This SEC filing is a formal document submitted by publicly-traded companies, and more information can be found on the SEC's website. [Extracted from the article]

Published
2024

17. Dynatronics Corp. Files SEC Form DEF 14A, Other Definitive Proxy Statements: (Oct. 25, 2024).

Subjects
SURGICAL instruments, MEDICAL equipment, PUBLIC companies, PROXY statements, SURGICAL technology
Abstract

Dynatronics Corp. filed a U.S. Securities and Exchange Commission (SEC) Form DEF 14A on October 25, 2024. The form pertains to non-management definitive proxy statements, typically for an annual meeting proxy. The company's contact information is located in Salt Lake City, Utah, and the SEC file number is 0001062993-24-017939. This filing is a formal document submitted by publicly-traded companies to the SEC, and more information can be found on the SEC's website. [Extracted from the article]

Published
2024

18. Strata Skin Sciences, Inc. Files SEC Form 3, Initial Statement of Beneficial Ownership of Securities: (Oct. 29, 2024).

Subjects
SURGICAL instruments, MEDICAL equipment, SURGICAL technology, PUBLIC companies, INDUSTRY classification
Abstract

Strata Skin Sciences, Inc. filed an SEC Form 3, an initial statement of beneficial ownership of securities, on October 29, 2024. The company's SIC code is 3841, relating to Surgical and Medical Instruments and Apparatus. This filing is a formal document submitted to the U.S. Securities and Exchange Commission by publicly-traded companies, providing information on ownership of equity securities. [Extracted from the article]

Published
2024

19. Atricure, Inc. Files SEC Form 8-K, Current Report: (Oct. 29, 2024).

Subjects
SURGICAL instruments, MEDICAL equipment, SECURITY holders, SURGICAL technology, PUBLIC companies
Abstract

Atricure, Inc. filed a Form 8-K with the U.S. Securities and Exchange Commission on October 29, 2024. The company's SIC code is 3841, indicating its focus on Surgical and Medical Instruments and Apparatus. Form 8-K is used to report material events or corporate changes that are important to investors and provides more current information than Forms 10-Q or 10-K. This filing is a formal document submitted by publicly-traded companies to the SEC, and more information can be found on the SEC's website. [Extracted from the article]

Published
2024

20. Penumbra Inc. Files SEC Form 8-K, Current Report: (Oct. 30, 2024).

Subjects
SURGICAL instruments, MEDICAL equipment, SECURITY holders, SURGICAL technology, PUBLIC companies
Abstract

Penumbra Inc. filed a Form 8-K with the U.S. Securities and Exchange Commission on October 30, 2024. The filing pertains to material events or corporate changes important to investors. Penumbra Inc. is a medical device company based in Alameda, California, specializing in surgical and medical instruments. The SEC filing can be accessed on the SEC website for further information. [Extracted from the article]

Published
2024

21. Catheter Precision, Inc. Files SEC Form 424B3, Prospectus [Rule 424(B)(3)]: (Oct. 25, 2024).

Subjects
MEDICAL equipment, SURGICAL instruments, SURGICAL technology, PUBLIC companies, INDUSTRY classification
Abstract

Catheter Precision, Inc. filed a Form 424B3 with the U.S. Securities and Exchange Commission on October 25, 2024. The company's SIC code is 3841, indicating its focus on Surgical and Medical Instruments and Apparatus. The filing is a final prospectus submitted in accordance with Rule 424(b)(3) and provides formal financial information about the company. For more details, the SEC filing can be accessed at the provided link. [Extracted from the article]

Published
2024

22. Inspiremd, Inc. Files SEC Form SC 13G/A, Statement of Beneficial Ownership By Certain Investors: (Oct. 28, 2024).

Subjects
SURGICAL instruments, MEDICAL equipment, SURGICAL technology, PUBLIC companies, INDUSTRY classification
Abstract

Inspiremd, Inc. filed a Form SC 13G/A with the U.S. Securities and Exchange Commission on October 28, 2024. The company operates in the Surgical and Medical Instruments and Apparatus industry, with a SIC code of 3841. This SEC filing is a formal document submitted by publicly-traded companies, and more information can be found on the SEC website. [Extracted from the article]

Published
2024

23. Bellevue Life Sciences Acquisition Corp. Files SEC Form 425, Prospectuses And Communications, Business Combinations: (Oct. 28, 2024).

Subjects
SURGICAL instruments, MEDICAL equipment, MERGERS & acquisitions, SURGICAL technology, PUBLIC companies
Abstract

Bellevue Life Sciences Acquisition Corp. filed a U.S. Securities and Exchange Commission (SEC) Form 425 on October 28, 2024, related to business combination transactions. The company's SIC code is 3841, focusing on Surgical and Medical Instruments and Apparatus. The filing is a formal document submitted by publicly-traded companies to the SEC, providing prospectuses and communications. For more information, the SEC filing can be accessed at https://www.sec.gov/Archives/edgar/data/1840425/0001193125-24-244728-index.html. [Extracted from the article]

Published
2024

24. Ebr Systems, Inc. Files SEC Form S-8, Securities To Be Offered To Employees in Employee Benefit Plans: (Oct. 28, 2024).

Subjects
SURGICAL instruments, MEDICAL equipment, EMPLOYEE benefits, SURGICAL technology, PUBLIC companies
Abstract

Ebr Systems, Inc. recently filed a Form S-8 with the U.S. Securities and Exchange Commission (SEC) on October 28, 2024. This form is used for the registration of securities to be offered to the company's employees as part of certain benefit plans. The SEC filing includes contact information for Ebr Systems, Inc. and can be accessed on the SEC's website for further details. The company operates in the surgical and medical instruments and apparatus industry, with its headquarters located in Sunnyvale, California. [Extracted from the article]

Published
2024

25. Solventum Corp. Files SEC Form SC 13G, Statement of Beneficial Ownership By Certain Investors: (Oct. 24, 2024).

Subjects
SURGICAL instruments, MEDICAL equipment, SURGICAL technology, INDUSTRY classification, PUBLIC companies
Abstract

Solventum Corp. filed a Form SC 13G with the U.S. Securities and Exchange Commission on October 24, 2024. The company's SIC code is 3841, indicating its involvement in Surgical and Medical Instruments and Apparatus. Schedule 13G is a condensed version of Schedule 13D, used by specific entities like banks and broker/dealers when acquiring securities without the intent to influence the issuer's control. This SEC filing is a formal document submitted by publicly-traded companies, providing financial information to the regulatory body. [Extracted from the article]

Published
2024

26. Strata Skin Sciences, Inc. Files SEC Form 4, Statement of Changes in Beneficial Ownership of Securities: (Oct. 30, 2024).

Subjects
SURGICAL instruments, MEDICAL equipment, SURGICAL technology, PUBLIC companies, INDUSTRY classification
Abstract

Strata Skin Sciences, Inc. filed a Form 4 with the U.S. Securities and Exchange Commission on October 30, 2024. The form pertains to changes in beneficial ownership of securities and is a requirement for directors, officers, or owners of more than ten percent of a class of equity securities. The filing is a formal document submitted by publicly-traded companies to the SEC, and more information can be found on the SEC's website. [Extracted from the article]

Published
2024

27. Prolung Inc. Files SEC Form 8-K, Current Report: (Oct. 29, 2024).

Subjects
SURGICAL instruments, MEDICAL equipment, SECURITY holders, SURGICAL technology, PUBLIC companies
Abstract

Prolung Inc. filed a Form 8-K with the U.S. Securities and Exchange Commission on October 29, 2024. The company's SIC code is 3841, indicating its focus on Surgical and Medical Instruments and Apparatus. This filing is a "current report" used to disclose material events or corporate changes important to investors. More information can be found on the SEC's website. [Extracted from the article]

Published
2024

28. Seastar Medical Holding Corp. Files SEC Form PRE 14A, Other Preliminary Proxy Statements: (Oct. 24, 2024).

Subjects
SURGICAL instruments, MEDICAL equipment, PROXY statements, SURGICAL technology, PUBLIC companies
Abstract

Seastar Medical Holding Corp. filed a Form PRE 14A with the U.S. Securities and Exchange Commission on October 24, 2024. The company's SIC code is 3841, indicating its involvement in Surgical and Medical Instruments and Apparatus. The filing contained 3 documents and can be accessed on the SEC website for further information. [Extracted from the article]

Published
2024

29. Inari Medical, Inc. Files SEC Form 144, Report of Proposed Sale of Securities: (Oct. 29, 2024).

Subjects
MEDICAL equipment, SURGICAL instruments, SURGICAL technology, PUBLIC companies, INDUSTRY classification
Abstract

In October 2024, Inari Medical, Inc. filed a Form 144 with the U.S. Securities and Exchange Commission (SEC) regarding the proposed sale of securities. The company's SIC code is 3841, indicating its focus on Surgical and Medical Instruments and Apparatus. Form 144 is required when the sale of restricted securities or securities held by an affiliate exceeds certain thresholds, providing transparency in financial transactions. For more details on this SEC filing, interested individuals can visit the SEC's website. [Extracted from the article]

Published
2024

30. Nevro Corp. Files SEC Form 4, Statement of Changes in Beneficial Ownership of Securities: (Oct. 28, 2024).

Subjects
MEDICAL equipment, SURGICAL instruments, PUBLIC companies, SURGICAL technology, INDUSTRY classification
Abstract

Nevro Corp. recently filed a Form 4 with the U.S. Securities and Exchange Commission on October 28, 2024. This filing is related to changes in beneficial ownership of securities and is a standard procedure for directors, officers, or significant shareholders of publicly-traded companies. The SEC filing provides important information about the relationship between the reporting person and the company, as well as details on purchases and sales of equity securities. The document can be accessed on the SEC's website for further information. [Extracted from the article]

Published
2024

31. Nexgel, Inc. Files SEC Form 8-K, Current Report: (Oct. 28, 2024).

Subjects
SURGICAL instruments, MEDICAL equipment, SECURITY holders, SURGICAL technology, PUBLIC companies
Abstract

Nexgel, Inc. filed a Form 8-K with the U.S. Securities and Exchange Commission on October 28, 2024. The company's SIC code is 3841, and the filing included 33 documents. Form 8-K is used to report material events or corporate changes that are important to investors. This filing provides more current information than Forms 10-Q or 10-K. [Extracted from the article]

Published
2024

32. Catheter Precision, Inc. Files SEC Form 8-K, Current Report: (Oct. 30, 2024).

Subjects
MEDICAL equipment, SURGICAL instruments, SECURITY holders, SURGICAL technology, PUBLIC companies
Abstract

Catheter Precision, Inc. filed a Form 8-K with the U.S. Securities and Exchange Commission on October 30, 2024. The company's SIC code is 3841, and the filing included 16 documents. Form 8-K is used to report material events or corporate changes that are important to investors. This filing provides more current information than Forms 10-Q or 10-K. [Extracted from the article]

Published
2024

33. Resmed Inc. Files SEC Form 8-K, Current Report: (Oct. 24, 2024).

Subjects
MEDICAL equipment, SURGICAL instruments, SECURITY holders, SURGICAL technology, PUBLIC companies
Abstract

Resmed Inc. filed a Form 8-K with the U.S. Securities and Exchange Commission on October 24, 2024. The filing pertains to material events or corporate changes important to investors. Resmed Inc. is a medical device company with a SIC code of 3841, specializing in surgical and medical instruments and apparatus. The filing can be accessed on the SEC's website for further information. [Extracted from the article]

Published
2024

34. Catheter Precision, Inc. Files SEC Form SC 13D/A, General Statement of Acquisition of Beneficial Ownership: (Oct. 30, 2024).

Subjects
MEDICAL equipment, SURGICAL instruments, SURGICAL technology, PUBLIC companies, INDUSTRY classification
Abstract

Catheter Precision, Inc. filed a Form SC 13D/A with the U.S. Securities and Exchange Commission on October 30, 2024. The company's SIC code is 3841, indicating its involvement in Surgical and Medical Instruments and Apparatus. The SEC filing is a formal document submitted by publicly-traded companies, and more information can be found on the SEC's website. [Extracted from the article]

Published
2024

35. Bellevue Life Sciences Acquisition Corp. Files SEC Form DEF 14A, Other Definitive Proxy Statements: (Oct. 28, 2024).

Subjects
SURGICAL instruments, MEDICAL equipment, PROXY statements, SURGICAL technology, PUBLIC companies
Abstract

Bellevue Life Sciences Acquisition Corp. filed a Form DEF 14A with the U.S. Securities and Exchange Commission on October 28, 2024. The company's SIC code is 3841, focusing on Surgical and Medical Instruments and Apparatus. This filing typically pertains to non-management definitive proxy statements, such as annual meeting proxies. For more information, the SEC filing can be accessed at the provided link. [Extracted from the article]

Published
2024

36. Alphatec Holdings, Inc. Files SEC Form 8-K, Current Report: (Oct. 30, 2024).

Subjects
SURGICAL instruments, MEDICAL equipment, SECURITY holders, SURGICAL technology, PUBLIC companies
Abstract

Alphatec Holdings, Inc. filed a Form 8-K with the U.S. Securities and Exchange Commission on October 30, 2024. The company's SIC code is 3841, indicating its focus on Surgical and Medical Instruments and Apparatus. The Form 8-K is used to report material events or corporate changes that are important to investors and provides more current information than Forms 10-Q or 10-K. For more details on this SEC filing, visit https://www.sec.gov/Archives/edgar/data/1350653/0000950170-24-119022-index.html. [Extracted from the article]

Published
2024

37. Procept Biorobotics Corp. Files SEC Form 424B5, Prospectus [Rule 424(B)(5)]: (Oct. 28, 2024).

Subjects
SURGICAL instruments, MEDICAL equipment, SURGICAL technology, PUBLIC companies, INDUSTRY classification
Abstract

Procept Biorobotics Corp. filed a Form 424B5 with the U.S. Securities and Exchange Commission on October 28, 2024. The company's SIC code is 3841, indicating its focus on Surgical and Medical Instruments and Apparatus. This filing is a formal document submitted by publicly-traded companies to the SEC, and more information can be found on the SEC's website. [Extracted from the article]

Published
2024

38. Monogram Technologies Inc. Files SEC Form PRE 14A, Other Preliminary Proxy Statements: (Oct. 30, 2024).

Subjects
SURGICAL instruments, MEDICAL equipment, PROXY statements, SURGICAL technology, PUBLIC companies
Abstract

Monogram Technologies Inc. filed a Form PRE 14A with the U.S. Securities and Exchange Commission on October 30, 2024. The company's SIC code is 3841, indicating its focus on Surgical and Medical Instruments and Apparatus. This filing is a preliminary proxy statement not related to a contested matter or merger/acquisition. More information can be found on the SEC's website. [Extracted from the article]

Published
2024

39. Bluejay Diagnostics, Inc. Files SEC Form 8-K, Current Report: (Oct. 24, 2024).

Subjects
SURGICAL instruments, MEDICAL equipment, SECURITY holders, SURGICAL technology, PUBLIC companies
Abstract

Bluejay Diagnostics, Inc. filed a Form 8-K with the U.S. Securities and Exchange Commission on October 24, 2024. The company's SIC code is 3841, indicating its focus on Surgical and Medical Instruments and Apparatus. This filing is a "current report" used to disclose material events or corporate changes important to investors. More information can be found on the SEC's website. [Extracted from the article]

Published
2024

40. Dariohealth Corp. Files SEC Form DEF 14A, Other Definitive Proxy Statements: (Oct. 24, 2024).

Subjects
SURGICAL instruments, MEDICAL equipment, PROXY statements, SURGICAL technology, PUBLIC companies
Abstract

Dariohealth Corp. filed a U.S. Securities and Exchange Commission (SEC) Form DEF 14A on October 24, 2024. The company's SIC code is 3841, and the SEC file number is 0001104659-24-111163. This filing typically pertains to non-management definitive proxy statements, such as annual meeting proxies. For more information, the SEC filing can be accessed at https://www.sec.gov/Archives/edgar/data/1533998/0001104659-24-111163-index.html. [Extracted from the article]

Published
2024

41. Bellevue Life Sciences Acquisition Corp. Files SEC Form 8-K, Current Report: (Oct. 28, 2024).

Subjects
SURGICAL instruments, MEDICAL equipment, SECURITY holders, SURGICAL technology, PUBLIC companies
Abstract

Bellevue Life Sciences Acquisition Corp. filed a Form 8-K with the U.S. Securities and Exchange Commission on October 28, 2024. The company's SIC code is 3841, focusing on Surgical and Medical Instruments and Apparatus. This filing is a "current report" used to disclose material events or corporate changes important to investors. More information can be found on the SEC's website. [Extracted from the article]

Published
2024

42. Stryker Corp. Files SEC Form 8-K, Current Report: (Oct. 29, 2024).

Subjects
SURGICAL instruments, MEDICAL equipment, SECURITY holders, SURGICAL technology, PUBLIC companies
Abstract

Stryker Corp. filed a Form 8-K with the U.S. Securities and Exchange Commission on October 29, 2024. This form is used to report material events or corporate changes that are important to investors and have not been previously reported. The filing provides current information on specific events and is a formal document submitted by publicly-traded companies. The SIC code for Stryker Corp. is 3841, Surgical and Medical Instruments and Apparatus. [Extracted from the article]

Published
2024

43. Tela Bio, Inc. Files SEC Form SC 13G/A, Statement of Beneficial Ownership By Certain Investors: (Oct. 28, 2024).

Subjects
SURGICAL instruments, MEDICAL equipment, SURGICAL technology, PUBLIC companies, INDUSTRY classification
Abstract

Tela Bio, Inc. filed a Form SC 13G/A with the U.S. Securities and Exchange Commission on October 28, 2024. The company operates in the Surgical and Medical Instruments and Apparatus industry, with a SIC code of 3841. The SEC filing is a formal document submitted by publicly-traded companies, and more information can be found on the SEC website. [Extracted from the article]

Published
2024

44. Vivos Inc. Files SEC Form 4, Statement of Changes in Beneficial Ownership of Securities: (Oct. 28, 2024).

Subjects
SURGICAL instruments, MEDICAL equipment, SURGICAL technology, PUBLIC companies, INDUSTRY classification
Abstract

Vivos Inc. filed a Form 4 with the U.S. Securities and Exchange Commission on October 28, 2024, as reported by NewsRx journalists in Washington, D.C. The company's SIC code is 3841, indicating its involvement in Surgical and Medical Instruments and Apparatus. Form 4 is required for directors, officers, or owners of more than ten percent of a class of equity securities to report changes in ownership. This SEC filing provides formal financial information for publicly-traded companies like Vivos Inc. [Extracted from the article]

Published
2024

45. Tela Bio, Inc. Files SEC Form 4, Statement of Changes in Beneficial Ownership of Securities: (Oct. 24, 2024).

Subjects
SURGICAL instruments, MEDICAL equipment, SURGICAL technology, PUBLIC companies, INDUSTRY classification
Abstract

Tela Bio, Inc. recently filed a Form 4 with the U.S. Securities and Exchange Commission (SEC) on October 24, 2024. The company's SIC code is 3841, indicating its involvement in Surgical and Medical Instruments and Apparatus. Form 4 is required for directors, officers, or owners of more than ten percent of a class of equity securities to report changes in ownership. This SEC filing is a formal document submitted by publicly-traded companies, and more information can be found on the SEC's website. [Extracted from the article]

Published
2024

46. Femasys Inc. Files SEC Form 8-K, Current Report: (Oct. 29, 2024).

Subjects
SURGICAL instruments, MEDICAL equipment, SECURITY holders, SURGICAL technology, PUBLIC companies
Abstract

Femasys Inc. recently filed a Form 8-K with the U.S. Securities and Exchange Commission on October 29, 2024. The filing, related to the company's SIC code 3841 for Surgical and Medical Instruments and Apparatus, included 41 documents and can be accessed on the SEC's website. Form 8-K is used to report material events or corporate changes that are important to investors, providing more current information than Forms 10-Q or 10-K. For more details on the SEC filing by Femasys Inc., visit https://www.sec.gov/Archives/edgar/data/1339005/0001140361-24-044486-index.html. [Extracted from the article]

Published
2024

47. Venus Concept Inc. Files SEC Form S-3, Registration Statement Under Securities Act of 1933: (Oct. 24, 2024).

Subjects
SURGICAL instruments, MEDICAL equipment, SURGICAL technology, PUBLIC companies, INDUSTRY classification
Abstract

Venus Concept Inc. filed a Form S-3 with the U.S. Securities and Exchange Commission on October 24, 2024. The company operates in the Surgical and Medical Instruments and Apparatus industry, with its contact information listed as 235 YORKLAND BLVD., SUITE 900, TORONTO A6 M2J 4Y8. Form S-3 is a simplified registration form for companies that have been reporting under the '34 Act for at least twelve months and have met timely filing requirements. This SEC filing is a formal document submitted by publicly-traded companies, and more information can be found on the SEC's website. [Extracted from the article]

Published
2024

48. Nu-med Plus, Inc. Files SEC Form 8-K, Current Report: (Oct. 30, 2024).

Subjects
SURGICAL instruments, MEDICAL equipment, SECURITY holders, SURGICAL technology, PUBLIC companies
Abstract

Nu-med Plus, Inc. filed a Form 8-K with the U.S. Securities and Exchange Commission on October 30, 2024. The company's SIC code is 3841, indicating its focus on Surgical and Medical Instruments and Apparatus. This filing is a "current report" used to disclose material events or corporate changes important to investors. More information can be found on the SEC's website. [Extracted from the article]

Published
2024

49. Beyond Air, Inc. Files SEC Form S-3, Registration Statement Under Securities Act of 1933: (Oct. 25, 2024).

Subjects
SURGICAL instruments, MEDICAL equipment, SURGICAL technology, PUBLIC companies, INDUSTRY classification
Abstract

Beyond Air, Inc. filed a Form S-3 with the U.S. Securities and Exchange Commission on October 25, 2024. The company's SIC code is 3841, indicating its involvement in Surgical and Medical Instruments and Apparatus. Form S-3 is a simplified registration form used by companies that have been reporting under the '34 Act for at least twelve months and have met specific filing requirements. This filing is a formal document submitted by publicly-traded companies to the SEC, and more information can be found on the SEC's website. [Extracted from the article]

Published
2024

50. Neuropace Inc. Files SEC Form 4, Statement of Changes in Beneficial Ownership of Securities: (Oct. 28, 2024).

Subjects
SURGICAL instruments, MEDICAL equipment, SURGICAL technology, PUBLIC companies, INDUSTRY classification
Abstract

Neuropace Inc. filed a Form 4 with the U.S. Securities and Exchange Commission on October 28, 2024, as reported by NewsRx journalists in Washington, D.C. The company's SIC code is 3841, indicating its involvement in Surgical and Medical Instruments and Apparatus. Form 4 is required for directors, officers, or owners of more than ten percent of a class of equity securities to report changes in ownership. This SEC filing is a formal document submitted by publicly-traded companies, providing information on ownership and transactions related to equity securities. [Extracted from the article]

Published
2024

Catalog

Books, media, physical & digital resources
See catalog results